These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 36038084)
21. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease. Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247 [TBL] [Abstract][Full Text] [Related]
22. Identification of the key molecules involved in chronic copper exposure-aggravated memory impairment in transgenic mice of Alzheimer's disease using proteomic analysis. Yu J; Luo X; Xu H; Ma Q; Yuan J; Li X; Chang RC; Qu Z; Huang X; Zhuang Z; Liu J; Yang X J Alzheimers Dis; 2015; 44(2):455-69. PubMed ID: 25352456 [TBL] [Abstract][Full Text] [Related]
23. Flavanol-rich lychee fruit extract substantially reduces progressive cognitive and molecular deficits in a triple-transgenic animal model of Alzheimer disease. Chen X; Xu B; Nie L; He K; Zhou L; Huang X; Spencer P; Yang X; Liu J Nutr Neurosci; 2021 Sep; 24(9):720-734. PubMed ID: 31603034 [TBL] [Abstract][Full Text] [Related]
24. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model. Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551 [TBL] [Abstract][Full Text] [Related]
25. TLR4 response mediates ethanol-induced neurodevelopment alterations in a model of fetal alcohol spectrum disorders. Pascual M; Montesinos J; Montagud-Romero S; Forteza J; Rodríguez-Arias M; Miñarro J; Guerri C J Neuroinflammation; 2017 Jul; 14(1):145. PubMed ID: 28738878 [TBL] [Abstract][Full Text] [Related]
26. Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease. Morin JP; Cerón-Solano G; Velázquez-Campos G; Pacheco-López G; Bermúdez-Rattoni F; Díaz-Cintra S J Alzheimers Dis; 2016; 51(1):69-79. PubMed ID: 26836189 [TBL] [Abstract][Full Text] [Related]
27. Postsynaptic Protein Shank3a Deficiency Synergizes with Alzheimer's Disease Neuropathology to Impair Cognitive Performance in the 3xTg-AD Murine Model. Landry O; François A; Oye Mintsa Mi-Mba MF; Traversy MT; Tremblay C; Emond V; Bennett DA; Gylys KH; Buxbaum JD; Calon F J Neurosci; 2023 Jun; 43(26):4941-4954. PubMed ID: 37253603 [TBL] [Abstract][Full Text] [Related]
28. Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer's disease. Stancu IC; Ris L; Vasconcelos B; Marinangeli C; Goeminne L; Laporte V; Haylani LE; Couturier J; Schakman O; Gailly P; Pierrot N; Kienlen-Campard P; Octave JN; Dewachter I FASEB J; 2014 Jun; 28(6):2620-31. PubMed ID: 24604080 [TBL] [Abstract][Full Text] [Related]
29. Chronic Gestational Exposure to Ethanol Leads to Enduring Aberrances in Cortical Form and Function in the Medial Prefrontal Cortex. Skorput AG; Yeh HH Alcohol Clin Exp Res; 2016 Jul; 40(7):1479-88. PubMed ID: 27242215 [TBL] [Abstract][Full Text] [Related]
31. Developmental ethanol exposure alters the morphology of mouse prefrontal neurons in a layer-specific manner. Louth EL; Luctkar HD; Heney KA; Bailey CDC Brain Res; 2018 Jan; 1678():94-105. PubMed ID: 29017910 [TBL] [Abstract][Full Text] [Related]
32. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease. Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994 [TBL] [Abstract][Full Text] [Related]
33. Short-term modern life-like stress exacerbates Aβ-pathology and synapse loss in 3xTg-AD mice. Baglietto-Vargas D; Chen Y; Suh D; Ager RR; Rodriguez-Ortiz CJ; Medeiros R; Myczek K; Green KN; Baram TZ; LaFerla FM J Neurochem; 2015 Sep; 134(5):915-26. PubMed ID: 26077803 [TBL] [Abstract][Full Text] [Related]
34. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice. Liu D; Zhao Y; Qi Y; Gao Y; Tu D; Wang Y; Gao HM; Zhou H J Neuroinflammation; 2020 Aug; 17(1):258. PubMed ID: 32867800 [TBL] [Abstract][Full Text] [Related]
35. Effects of DDT on Amyloid Precursor Protein Levels and Amyloid Beta Pathology: Mechanistic Links to Alzheimer's Disease Risk. Eid A; Mhatre-Winters I; Sammoura FM; Edler MK; von Stein R; Hossain MM; Han Y; Lisci M; Carney K; Konsolaki M; Hart RP; Bennett JW; Richardson JR Environ Health Perspect; 2022 Aug; 130(8):87005. PubMed ID: 35946953 [TBL] [Abstract][Full Text] [Related]
36. Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer's Disease: Implications from a Transgenic Mouse Model of the Disease. Baazaoui N; Flory M; Iqbal K J Alzheimers Dis; 2017; 56(4):1385-1401. PubMed ID: 28222506 [TBL] [Abstract][Full Text] [Related]
37. Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis. Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM BMC Neurosci; 2018 Jul; 19(1):46. PubMed ID: 30055565 [TBL] [Abstract][Full Text] [Related]
39. A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse). Chen Y; Liang Z; Blanchard J; Dai CL; Sun S; Lee MH; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX Mol Neurobiol; 2013 Apr; 47(2):711-25. PubMed ID: 23150171 [TBL] [Abstract][Full Text] [Related]
40. Intermittent Hypoxic Conditioning Rescues Cognition and Mitochondrial Bioenergetic Profile in the Triple Transgenic Mouse Model of Alzheimer's Disease. Correia SC; Machado NJ; Alves MG; Oliveira PF; Moreira PI Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466445 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]